EP Patent

EP0103991A3 — Analgesic capsule

Assigned to Bristol Myers Squibb Co · Expires 1985-05-22 · 41y expired

What this patent protects

An analgesic capsule containing enteric coated aspirin granules and powdered APAP (p-acetylaminophenol).

USPTO Abstract

An analgesic capsule containing enteric coated aspirin granules and powdered APAP (p-acetylaminophenol).

Drugs covered by this patent

carvedilol-phosphate (CARVEDILOL PHOSPHATE)

Patent Metadata

Patent number: EP0103991A3
Jurisdiction: EP
Classification: —
Expires: 1985-05-22
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.